Harler Mary Beth
Chief Executive Officer at IGMS
- Sold, on record
- $71k
- Dollars the filings state
- Form 4 sales
- 6
- Latest Jul 23, 2025
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- IGMSIGM Biosciences, Inc.Chief Executive Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale IGMSNo planJun 14 2024
Sold 1,570 shares at $7.58 ($12k)
Harler Mary Beth, Head, Research & Autoimmunity
No 10b5-1 planSold 1.8% of holdings ($658k position)85,227 shares leftFirst sale on recordFiling
- 2 Form 4 sale IGMSNo planSep 13 +91 days
Sold 1,487 shares at $11.54 ($17k)
Harler Mary Beth, Head, Research & Autoimmunity
No 10b5-1 planSold 0.9% of holdings ($1.9M position)163,740 shares leftFiling
- 3 Form 4 sale IGMSNo planDec 16 +94 days
Sold 1,708 shares at $7.48 ($13k)
Harler Mary Beth, Chief Executive Officer
No 10b5-1 planSold 0.5% of holdings ($2.6M position)347,032 shares leftFiling
- 4 Form 4 sale IGMSUnusualMar 14 +88 days
Sold 7,329 shares at $1.23 ($9k)
Harler Mary Beth, Chief Executive Officer
No 10b5-1 planSold 2.1% of holdings ($427k position)339,703 shares left4.7x usual sizeFiling
- 5 Form 4 sale IGMSNo planJun 16 +94 days
Sold 1,522 shares at $1.20 ($2k)
Harler Mary Beth, Chief Executive Officer
No 10b5-1 planSold 0.4% of holdings ($408k position)338,181 shares left0.9x usual sizeFiling
- 6 Form 4 sale IGMSUnusualJul 23 +37 days
Sold 14,501 shares at $1.27 ($18k)
Harler Mary Beth, Chief Executive Officer
No 10b5-1 planSold 4.3% of holdings ($429k position)323,680 shares left9.2x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (6)
| Source | ||||||||
|---|---|---|---|---|---|---|---|---|
| Jul 23, 2025 | IGMS | Chief Executive Officer | Form 4 sale | 14,501 | $18k | 4.3% | Unusual | SEC |
| Jun 16, 2025 | IGMS | Chief Executive Officer | Form 4 sale | 1,522 | $2k | 0.4% | No plan | SEC |
| Mar 14, 2025 | IGMS | Chief Executive Officer | Form 4 sale | 7,329 | $9k | 2.1% | Unusual | SEC |
| Dec 16, 2024 | IGMS | Chief Executive Officer | Form 4 sale | 1,708 | $13k | 0.5% | No plan | SEC |
| Sep 13, 2024 | IGMS | Head, Research & Autoimmunity | Form 4 sale | 1,487 | $17k | 0.9% | No plan | SEC |
| Jun 14, 2024 | IGMS | Head, Research & Autoimmunity | Form 4 sale | 1,570 | $12k | 1.8% | No plan | SEC |